While top-line growth remains strong, a deeper dive reveals growing reliance on GLP-1 sales, softening core metrics, and signs of pressure beneath the surface
Said Express Scripts Behm: Over the past few years, a number of type 2 diabetes medications have demonstrated that they not only reduce blood glucose levels, but they also may reduce long-term cardiovascular risk
"Our research highlights the safety and the potential for GLP-1 receptor agonists [like semaglutide] to reduce the risk of acute pancreatitis recurrence in individuals with obesity and Type 2 diabetes, challenging previous concerns and offering new hope for effective disease management," Nassar said
Alcohol, Arachidyl Glucoside, Glutathione(0.0511%), Ethylexyglycerin, Adenosine, Cetearyl Alcohol, Disodium EDTA, Fragrance, Hydrolyzed Hyaluronic Acid, Hyaluronic Acid, Sodium Hyaluronate, Sodium DNA, Ceramide NP, Dioscorea Japonica Root Extract, Aloe Barbadensis Leaf Extract, Ammonium Polyacryloyldimethyl Taurate, Laminaria Japonica Extract, Ulmus Davidiana Root Extract, Visia Mandshurica Flower Extract, Plumeria Rubra Flower Extract, Ascorbic Acid, Panthenol, Tranexamic Acid, Cetyi Ethylhexanoate, Angelica Keiskei Extract, Corchorus Olitorius Leaf Extract, Hibiscus Esculentus Fruit Extract, Nelumbo Nucifera Root Extract, Caprylic/Capric Triglyceride, Ethylexyl Palmitate, Ethylhexy
Ketosis vs